Profusa, Inc. 8K

Profusa Inc. and Bio Insights LLC amended their asset purchase agreement to eliminate the planned issuance of management retention shares and make related conforming changes.

Profusa Inc. and Bio Insights LLC entered into a First Amendment to their April 21, 2026 Asset Purchase Agreement for the PanOmics Platform, effective May 22, 2026, under which they removed Section 4.6 that had required issuance of management retention shares equal to 12% of Profusa’s fully diluted common stock post-closing and deleted the defined term and all references to “Management Shares,” while making a conforming change to Section 3.3(c) so that board resolutions now relate to actions contemplated by Section 4.7, with all other terms of the original agreement remaining in full force and effect.

Filing Facts

CIK

1859807

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-060879

Alert Tier

6